Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.
about
Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivorsQuantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.Investigating verbal and visual auditory learning after conformal radiation therapy for childhood ependymoma.Cognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia.Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.Utility of the N-back task in survivors of childhood acute lymphoblastic leukemia.F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI.Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence?Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy.Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia SurvivorsComparison of intelligence quotient in children surviving leukemia who received different prophylactic central nervous system treatmentsSmaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation.Evidence-based assessment of cognitive functioning in pediatric psychology.Voxel-based analysis of T2 hyperintensities in white matter during treatment of childhood leukemia.Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia.Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort.Brain structure, working memory and response inhibition in childhood leukemia survivors.How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on MethotrexateMonitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology.Identification of likely associations between cerebral folate deficiency and complex genetic- and metabolic pathogenesis of autism spectrum disorders by utilization of a pilot interaction modeling approach.Clinical trials in pediatric neuro-oncology: what is missing and how we can improve.The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: A systematic review.A meta-analysis of the neuropsychological effects of chemotherapy in the treatment of childhood cancer.Brain volume and cognitive function in adult survivors of childhood acute lymphoblastic leukemia.Longitudinal language outcomes following intrathecal chemotherapy for acute lymphoblastic leukaemia.Neuropsychological assessment in a case of adult-onset hemophagocytic lymphohistiocytosis (HLH).Parental stress predicts functional outcome in pediatric cancer survivors.Impact of acute lymphoblastic leukemia therapy on attention and working memory in children.
P2860
Q26825655-2E226245-9BBE-4123-B6A8-CC125F2CD038Q33291796-3804E4D1-8D0B-4AC0-9BD9-0FCD28EE2F31Q34569234-80547277-374E-49F0-A821-EA29DFEE4803Q34630002-438CB2D6-3408-40DF-B839-ADD8D7BE2FABQ35098712-EF06B921-4634-4F60-938D-55181292FAF5Q35166450-86744574-6491-4405-8F77-F6B786B9DC81Q35557328-938F6E02-2F03-43C4-9656-52E38DDE318BQ35560127-F83C87B2-2A2E-4318-84C2-105857828B1DQ35580998-734012BC-7295-4188-8B1B-88AB311C02CBQ35736047-AA473F16-A2D5-449D-B934-691A98BE655FQ36082861-84855A06-8795-46CC-AC8D-955800C1A30FQ36445713-C467E214-12D5-4ABC-8048-1E609D2AF0E4Q36529449-E7FA0E86-E72B-4BF5-9422-972CA1E2C585Q36677462-411C6EB8-6A41-4672-84EA-C973D6F7E254Q36677590-C97604CA-0F0C-4AAC-95A4-E7F6A3B78A9BQ37056954-AFB24E30-F82A-4DA7-BDFF-57B4BA0EF7A8Q37438016-188F0A4F-F3A2-48F5-9457-849F3DBDBA5EQ37592244-C9FFCFA1-B53D-4703-B6E1-D012956CABBEQ37592251-D47B683A-B296-4262-AA3A-DEB20BE90464Q37653619-B6614FF0-355B-46C4-B137-E4A8F4019759Q38137967-AD2FB1B5-CBD4-47EA-98CD-73AD6E3C8A3BQ38580062-8F16037C-9004-4D18-9394-451A22D59E18Q38678301-BAEA37FF-A67B-4BA4-AB13-DACC8A3A7457Q38879318-72B5D48E-09AB-4200-8013-63D93DD01863Q38951440-930F8A51-382A-4383-80EB-477365D4486CQ38970742-4608EDF3-D7AB-4874-8D88-11D9BA3CBEF5Q39555029-978E88AB-509A-4D61-91AE-F924BBD20C9AQ40033058-2366C797-4C04-43D5-90A8-4A61E64C5B04Q44326589-3141D013-0C76-481B-8D6F-5FA349BC0234Q45037116-0199B3B7-7DE6-4A1A-A5E6-6578EAD29C59Q50687582-44975216-D0F1-4B4C-8DF6-F57782015EA1Q51030080-49D2942D-1DB2-4844-A325-5E4031559346
P2860
Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cognitive changes in children ...... Oncology Group 9605 protocol.
@en
Cognitive changes in children ...... Oncology Group 9605 protocol.
@nl
type
label
Cognitive changes in children ...... Oncology Group 9605 protocol.
@en
Cognitive changes in children ...... Oncology Group 9605 protocol.
@nl
prefLabel
Cognitive changes in children ...... Oncology Group 9605 protocol.
@en
Cognitive changes in children ...... Oncology Group 9605 protocol.
@nl
P2093
P2860
P1476
Cognitive changes in children ...... Oncology Group 9605 protocol.
@en
P2093
Daniel L Keene
Elizabeth Hsu
Hal Dunlap
Isabelle Montour-Proulx
Jacqueline M Halton
Mary-Ann Matzinger
Sally M Kuehn
P2860
P304
P356
10.1177/08830738050200020901
P577
2005-02-01T00:00:00Z